Targeting exonucleases for cancer therapy is an emerging area of research. By understanding the specific exonuclease mutations and their role in cancer, researchers can develop targeted therapies to exploit these vulnerabilities. For example, inhibiting exonuclease activity in cancer cells with defective DNA repair pathways can increase their sensitivity to DNA-damaging agents, making them more susceptible to chemotherapy and radiation therapy.
